{
    "startDate": "2018-04-01",
    "endDate": "2018-12-31",
    "year": "2019",
    "quarter": "Q3",
    "symbol": "UROV",
    "data": {
        "bs": [
            {
                "label": "Cash",
                "concept": "Cash",
                "unit": "usd",
                "value": 95613000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashCurrent",
                "unit": "usd",
                "value": 244000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 15140000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 110997000
            },
            {
                "label": "Furniture and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 571000
            },
            {
                "label": "Restricted cash, net of current portion",
                "concept": "RestrictedCashNoncurrent",
                "unit": "usd",
                "value": 600000
            },
            {
                "label": "Other assets",
                "concept": "AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 84000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 112252000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 3696000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 6365000
            },
            {
                "label": "Due to Roivant Sciences Ltd.",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 33000
            },
            {
                "label": "Liabilities and Shareholders' Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 10094000
            },
            {
                "label": "Commitments and contingencies (Note 8)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common shares, par value $0.000037453 per share, 267,001,308 shares authorized, 30,322,911 and 20,025,098 issued and outstanding at December 31, 2018 and March 31, 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Common shares subscribed",
                "concept": "CommonStockShareSubscribedButUnissuedSubscriptionsReceivable",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 320000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 248401000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -146563000
            },
            {
                "label": "Shareholders' equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 102158000
            },
            {
                "label": "Liabilities and Shareholders' Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 112252000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -82378000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 132000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 2628000
            },
            {
                "label": "Unrealized foreign currency translation adjustment",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": -313000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 9944000
            },
            {
                "label": "Due to Roivant Sciences Ltd.",
                "concept": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": -1449000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 2863000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 2770000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -85065000
            },
            {
                "label": "Purchases of furniture and equipment",
                "concept": "PaymentsToAcquireFurnitureAndFixtures",
                "unit": "usd",
                "value": 193000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -193000
            },
            {
                "label": "Proceeds from capital contributions from Roivant Sciences Ltd.",
                "concept": "ProceedsFromContributedCapital",
                "unit": "usd",
                "value": 41590000
            },
            {
                "label": "Proceeds from issuance of common shares in initial public offering, net of offering costs",
                "concept": "ProceedsFromIssuanceInitialPublicOffering",
                "unit": "usd",
                "value": 132931000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 174521000
            },
            {
                "label": "Net change in cash and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 89263000
            },
            {
                "label": "Income taxes",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 174000
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 69308000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 12650000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 81958000
            },
            {
                "label": "Other income (expense):",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -299000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -82257000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 121000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -82378000
            },
            {
                "label": "Net loss per common share\u2014basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -3.51
            },
            {
                "label": "Weighted average common shares outstanding\u2014basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 23450692
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 313000
            },
            {
                "label": "Other comprehensive income (loss):",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 313000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -82065000
            }
        ]
    }
}